Alfuzosin (sold as Uroxatral) has an elimination half-life of approximately 10 hours in the extended-release form most commonly prescribed. That means it takes roughly 50 hours, or just over two days, for your body to clear the drug almost entirely after your last dose. This estimate is based on the standard pharmacology rule that a drug is considered eliminated after about five half-lives.
How Alfuzosin Leaves Your Body
The liver does the heavy lifting when it comes to breaking down alfuzosin. A specific liver enzyme called CYP3A4 is the principal pathway for its metabolism, and the process is extensive: only 11% of a dose leaves the body unchanged through urine. The rest is converted into inactive byproducts that have no pharmacological effect. Because the metabolites are inactive, the timeline that matters most is how long the parent drug circulates at meaningful levels, which is captured by that roughly two-day window.
The extended-release tablet is designed to release alfuzosin slowly throughout the day. Peak blood levels occur about 8 hours after you take it with food. This slow absorption profile is part of what gives the drug its 10-hour half-life in practice, compared to the shorter half-life seen with immediate-release formulations available in some countries.
Food Makes a Significant Difference
Alfuzosin is meant to be taken after a meal. When taken on an empty stomach, absorption drops considerably, which changes both how well the drug works and how it moves through your system. The extended-release formulation specifically relies on food to maintain a steady, predictable release pattern. If you’ve been taking it without food, the drug may clear faster simply because less of it was absorbed in the first place.
Liver Health Has the Biggest Impact
Your liver’s ability to process alfuzosin is the single most important factor determining how long the drug stays in your system. In people with moderate to severe liver impairment, the body’s ability to clear alfuzosin drops to roughly one-quarter of normal. The practical result: blood levels of the drug run three to four times higher than in someone with a healthy liver, and the drug lingers significantly longer. This effect is serious enough that alfuzosin is contraindicated, meaning it should not be used at all, in people with moderate to severe liver disease.
If you have mild liver problems, clearance may still be somewhat slower than average, meaning the two-day estimate could stretch longer for you.
Kidney Function Plays a Smaller Role
Since most alfuzosin is processed by the liver rather than filtered through the kidneys, reduced kidney function has a more modest effect. People with mild, moderate, or severe kidney impairment show peak blood levels and overall drug exposure about 50% higher than those with normal kidney function. In clinical trials, people with mild or moderate kidney impairment tolerated the drug similarly to those with normal function. Data on people with severely reduced kidney function is limited to only a handful of patients, so the timeline for full clearance in that group is less certain but likely extends beyond the typical two-day window.
What About Side Effects After Stopping?
Alfuzosin works by relaxing smooth muscle in the prostate and bladder neck, which is why it helps with urinary symptoms from an enlarged prostate. The flip side is that it also relaxes blood vessels, which can cause dizziness or lightheadedness, especially when standing up quickly. These effects generally track with how much drug is still circulating in your blood.
After your last dose, you can expect any side effects to fade over the same roughly two-day clearance window. The first 10 hours (one half-life) will see the biggest drop in drug levels, so most people notice improvement in side effects like dizziness within the first day. By 48 to 50 hours, levels are low enough that the drug is functionally out of your system.
Factors That Could Extend the Timeline
Several things can slow alfuzosin’s clearance beyond the standard two-day estimate:
- CYP3A4 inhibitors: Certain medications block the same liver enzyme that breaks down alfuzosin. Common examples include ketoconazole (an antifungal), ritonavir (an HIV medication), and some antibiotics like clarithromycin. Taking any of these alongside alfuzosin can raise blood levels substantially and keep the drug in your system longer.
- Liver impairment: As noted, even mild liver issues can slow clearance. Moderate to severe liver disease can extend the timeline dramatically.
- Kidney impairment: Adds roughly 50% more drug exposure, which may push the clearance window out by half a day to a day.
Age Does Not Seem to Matter
One factor that does not appear to change the timeline is age. Pharmacokinetic studies comparing elderly patients to younger adults found no meaningful difference in how much drug reaches the bloodstream or how quickly it is cleared. Since alfuzosin is primarily prescribed to older men for prostate-related urinary symptoms, this is reassuring: the two-day clearance estimate applies across age groups, assuming normal liver and kidney function.